News

RAS inhibitor daraxonrasib demonstrates initial anti-tumour activity in pancreatic cancer

RAS(ON) inhibitor daraxonrasib shows promising results in advanced pancreatic cancer phase 1/2 study

Study identifies new strategy to overcome immunotherapy resistance in colorectal cancer

Scientists find blood-based biomarkers for inflammatory breast cancer

Protecting children receiving cancer treatment from infections

Researchers develop first blood test to map tumour “neighbourhoods,” improving prediction of therapy response

New vesicle links sperm development and gastric cancer

Rare dual-mutation GIST responds to targeted therapy, challenging established tumour biology

lncRNA ROLLCSC: A prognostic marker and therapeutic target for lung adenocarcinoma

A blood test reveals ‘neighborhoods’ of cells in tumours, predicts immunotherapy responses

Yanghe Decoction inhibits osteosarcoma progression

Artificial intelligence in pathology enables a deeper understanding of cancer